12.5%) who maintained about a 25% weight loss compared to the under 5% weight loss in the nonsurgical group. All-cause mortality was also 37% less for bariatric surgery patients (9.1% vs.
Patients were followed until September 2022 for MACE, a composite of all-cause death or cardiovascular disease.Īfter 10 years, MACE occurred in 27% of patients in the bariatric surgery group compared to 35.6% in the nonsurgical group. In the cohort study of 13,657 Cleveland Clinic patients with a diagnosis of obesity and moderate to severe OSA, 970 patients had gastric bypass or sleeve gastrectomy while 12,687 matched patients received CPAP or usual non-surgical care between 20. “Bariatric surgery is a very powerful tool that can help patients with sleep apnea live longer and healthier lives.” “No other therapy has been shown to reduce the risk of dying or developing heart attack or heart failure in patients with obesity and obstructive sleep apnea,” said the study lead author Ali Aminian, MD, Director of Bariatric and Metabolic Institute at the Cleveland Clinic and a Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. Standard treatment is with continuous positive airway pressure (CPAP), but the therapy only addresses symptoms, is not curative and does not reduce the risk of MACE or death, which has a high incidence among patients with OSA.
Obesity can cause excess fat to deposit around the upper airway, which can compress the upper airways and interfere with breathing during sleep. OSA is a dangerous sleep disorder that effects nearly 1 billion adults worldwide - about 70% also have obesity. Researchers also report metabolic surgery patients cut their risk of death by nearly 40%. LAS VEGAS – J– Bariatric surgery, also called weight-loss or metabolic surgery, was associated with a 42% lower risk of major adverse cardiovascular events (MACE), including heart failure, heart attack, stroke, and atrial fibrillation in patients with moderate to severe obstructive sleep apnea (OSA), according to a new study from Cleveland Clinic and presented here today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting.
0 kommentar(er)
